{"id":"https://openalex.org/W4230920175","doi":"https://doi.org/10.1200/jco.2019.37.7_suppl.tps335","title":"ProSTAR: A phase Ib/II study of CPI-1205, a small molecule inhibitor of EZH2, combined with enzalutamide (E) or abiraterone/prednisone (A/P) in patients with metastatic castration-resistant prostate cancer (mCRPC).","display_name":"ProSTAR: A phase Ib/II study of CPI-1205, a small molecule inhibitor of EZH2, combined with enzalutamide (E) or abiraterone/prednisone (A/P) in patients with metastatic castration-resistant prostate cancer (mCRPC).","publication_year":2019,"publication_date":"2019-03-01","ids":{"openalex":"https://openalex.org/W4230920175","doi":"https://doi.org/10.1200/jco.2019.37.7_suppl.tps335"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2019.37.7_suppl.tps335","doi":"https://doi.org/10.1200/jco.2019.37.7_suppl.tps335","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2019.37.7_suppl.tps335","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023517416","display_name":"Mary\u2010Ellen Taplin","orcid":"https://orcid.org/0000-0002-3384-0300","observed_orcids":["https://orcid.org/0000-0002-3384-0300"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mary-Ellen Taplin","raw_affiliation_strings":["Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101562696","display_name":"Arif Hussain","orcid":"https://orcid.org/0000-0001-8485-4406","observed_orcids":["https://orcid.org/0000-0001-8485-4406"]},"institutions":[{"id":"https://openalex.org/I126744593","display_name":"University of Maryland, Baltimore","ror":"https://ror.org/04rq5mt64","country_code":"US","type":"education","lineage":["https://openalex.org/I126744593"]},{"id":"https://openalex.org/I4390039317","display_name":"University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center","ror":"https://ror.org/01vft3j45","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I14285509","https://openalex.org/I4390039317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Arif Hussain","raw_affiliation_strings":["University of Maryland Cancer Center, Baltimore, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Maryland Cancer Center, Baltimore, MD;","institution_ids":["https://openalex.org/I126744593","https://openalex.org/I4390039317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109431602","display_name":"Satish Kumar Shah","orcid":"https://orcid.org/0000-0003-2716-4091","observed_orcids":["https://orcid.org/0000-0003-2716-4091"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Satish Shah","raw_affiliation_strings":["Gettysburg Cancer Ctr, Gettysburg, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gettysburg Cancer Ctr, Gettysburg, PA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088518998","display_name":"Neal D. Shore","orcid":"https://orcid.org/0000-0001-5767-0548","observed_orcids":["https://orcid.org/0000-0001-5767-0548"]},"institutions":[{"id":"https://openalex.org/I4210165013","display_name":"Carolina Urologic Research Center","ror":"https://ror.org/05vk9vy20","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210165013"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Neal D. Shore","raw_affiliation_strings":["Carolina Urologic Research Center, Myrtle Beach, SC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Carolina Urologic Research Center, Myrtle Beach, SC;","institution_ids":["https://openalex.org/I4210165013"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083533154","display_name":"Manish Agrawal","orcid":"https://orcid.org/0000-0001-8208-0582","observed_orcids":["https://orcid.org/0000-0001-8208-0582"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Manish Agrawal","raw_affiliation_strings":["Associates in Oncology, Rockville, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Associates in Oncology, Rockville, MD;","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"William Clark","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William Clark","raw_affiliation_strings":["Alaska Clinical Research Center, Anchorage, AK;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alaska Clinical Research Center, Anchorage, AK;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006591586","display_name":"William Jeffery Edenfield","orcid":"https://orcid.org/0000-0001-8232-2318","observed_orcids":["https://orcid.org/0000-0001-8232-2318"]},"institutions":[{"id":"https://openalex.org/I1283654650","display_name":"Prisma Health","ror":"https://ror.org/03n7vd314","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1283654650"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William Jeffery Edenfield","raw_affiliation_strings":["Greenville Health System Cancer Institute, Greenville, SC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Greenville Health System Cancer Institute, Greenville, SC;","institution_ids":["https://openalex.org/I1283654650"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015581478","display_name":"Luke T. Nordquist","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210107510","display_name":"Urology Cancer Center and GU Research Network","ror":"https://ror.org/01hyb7g80","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210107510"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Luke T. Nordquist","raw_affiliation_strings":["Urology Cancer Center and GU Research Network, Omaha, NE;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Urology Cancer Center and GU Research Network, Omaha, NE;","institution_ids":["https://openalex.org/I4210107510"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103851087","display_name":"Oliver A. Sartor","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114832834","display_name":"Tulane University","ror":"https://ror.org/04vmvtb21","country_code":"US","type":"education","lineage":["https://openalex.org/I114832834"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Oliver A Sartor","raw_affiliation_strings":["Tulane University School of Medicine, New Orleans, LA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tulane University School of Medicine, New Orleans, LA;","institution_ids":["https://openalex.org/I114832834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087253387","display_name":"James Edward Butrynski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801703863","display_name":"Overlake Hospital Medical Center","ror":"https://ror.org/004hxna20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801703863"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James E. Butrynski","raw_affiliation_strings":["Overlake Med Clinics, Bellevue, WA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Overlake Med Clinics, Bellevue, WA;","institution_ids":["https://openalex.org/I2801703863"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089256383","display_name":"Gurkamal S. Chatta","orcid":"https://orcid.org/0000-0002-3154-9042","observed_orcids":["https://orcid.org/0000-0002-3154-9042"]},"institutions":[{"id":"https://openalex.org/I1317886745","display_name":"Virginia Mason Medical Center","ror":"https://ror.org/00cm2cb35","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1317886745","https://openalex.org/I2802797007","https://openalex.org/I4210118434"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gurkamal S. Chatta","raw_affiliation_strings":["Virginia Mason Medical Center, Seattle, WA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Virginia Mason Medical Center, Seattle, WA;","institution_ids":["https://openalex.org/I1317886745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081246052","display_name":"Mark T. Fleming","orcid":"https://orcid.org/0000-0001-9120-9587","observed_orcids":["https://orcid.org/0000-0001-9120-9587"]},"institutions":[{"id":"https://openalex.org/I4210088931","display_name":"Virginia Oncology Associates","ror":"https://ror.org/009yyqs39","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210088931"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark T. Fleming","raw_affiliation_strings":["Virginia Oncology Associates, US Oncology Research, Norfolk, VA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Virginia Oncology Associates, US Oncology Research, Norfolk, VA;","institution_ids":["https://openalex.org/I4210088931"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078027978","display_name":"William K. Oh","orcid":"https://orcid.org/0000-0001-5113-8147","observed_orcids":["https://orcid.org/0000-0001-5113-8147"]},"institutions":[{"id":"https://openalex.org/I4390039328","display_name":"Tisch Cancer Institute","ror":"https://ror.org/0317dzj93","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1320796813","https://openalex.org/I4390039328","https://openalex.org/I98704320"]},{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William K. Oh","raw_affiliation_strings":["Icahn School of Medicine at Mount Sinai Tisch Cancer Institute, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Icahn School of Medicine at Mount Sinai Tisch Cancer Institute, New York, NY;","institution_ids":["https://openalex.org/I4390039328","https://openalex.org/I98704320"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087198965","display_name":"Bill Bradley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210146481","display_name":"Constellation Pharmaceuticals (United States)","ror":"https://ror.org/04dxbz091","country_code":"US","type":"company","lineage":["https://openalex.org/I4210146481"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bill Bradley","raw_affiliation_strings":["Constellation Pharmaceuticals, Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Constellation Pharmaceuticals, Cambridge, MA;","institution_ids":["https://openalex.org/I4210146481"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084422325","display_name":"Jessica C. Piel","orcid":"https://orcid.org/0009-0003-8299-5370","observed_orcids":["https://orcid.org/0009-0003-8299-5370"]},"institutions":[{"id":"https://openalex.org/I4210146481","display_name":"Constellation Pharmaceuticals (United States)","ror":"https://ror.org/04dxbz091","country_code":"US","type":"company","lineage":["https://openalex.org/I4210146481"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jessica Piel","raw_affiliation_strings":["Constellation Pharmaceuticals, Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Constellation Pharmaceuticals, Cambridge, MA;","institution_ids":["https://openalex.org/I4210146481"]}]},{"author_position":"middle","author":{"id":null,"display_name":"David Nash","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210146481","display_name":"Constellation Pharmaceuticals (United States)","ror":"https://ror.org/04dxbz091","country_code":"US","type":"company","lineage":["https://openalex.org/I4210146481"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Nash","raw_affiliation_strings":["Constellation Pharmaceuticals, Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Constellation Pharmaceuticals, Cambridge, MA;","institution_ids":["https://openalex.org/I4210146481"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016229715","display_name":"Gozde Colak","orcid":"https://orcid.org/0000-0002-2450-9165","observed_orcids":["https://orcid.org/0000-0002-2450-9165"]},"institutions":[{"id":"https://openalex.org/I4210146481","display_name":"Constellation Pharmaceuticals (United States)","ror":"https://ror.org/04dxbz091","country_code":"US","type":"company","lineage":["https://openalex.org/I4210146481"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gozde Colak","raw_affiliation_strings":["Constellation Pharmaceuticals, Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Constellation Pharmaceuticals, Cambridge, MA;","institution_ids":["https://openalex.org/I4210146481"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100402457","display_name":"Jian Li","orcid":"https://orcid.org/0000-0001-9981-4650","observed_orcids":["https://orcid.org/0000-0001-9981-4650"]},"institutions":[{"id":"https://openalex.org/I4210146481","display_name":"Constellation Pharmaceuticals (United States)","ror":"https://ror.org/04dxbz091","country_code":"US","type":"company","lineage":["https://openalex.org/I4210146481"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jian Li","raw_affiliation_strings":["Constellation Pharmaceuticals, Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Constellation Pharmaceuticals, Cambridge, MA;","institution_ids":["https://openalex.org/I4210146481"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056376840","display_name":"Claudia A. Lebedinsky","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210146481","display_name":"Constellation Pharmaceuticals (United States)","ror":"https://ror.org/04dxbz091","country_code":"US","type":"company","lineage":["https://openalex.org/I4210146481"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Claudia Lebedinsky","raw_affiliation_strings":["Constellation Pharmaceuticals, Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Constellation Pharmaceuticals, Cambridge, MA;","institution_ids":["https://openalex.org/I4210146481"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5018645768","display_name":"Emmanuel S. Antonarakis","orcid":"https://orcid.org/0000-0003-0031-9655","observed_orcids":["https://orcid.org/0000-0003-0031-9655","https://orcid.org/0000-0003-3531-3851"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Emmanuel S. Antonarakis","raw_affiliation_strings":["Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD;","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I4210164401"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":15,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":18,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"37","issue":"7_suppl","first_page":"TPS335","last_page":"TPS335"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10124","display_name":"Prostate Cancer Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ezh2-inhibitors","display_name":"EZH2 inhibitors","score":0.9070000052452087},{"id":"https://openalex.org/keywords/metastatic-castration-resistant-prostate-cancer","display_name":"metastatic castration-resistant prostate cancer","score":0.9240000247955322},{"id":"https://openalex.org/keywords/enzalutamide","display_name":"enzalutamide","score":0.996999979019165},{"id":"https://openalex.org/keywords/abiraterone-acetate","display_name":"abiraterone","score":0.8259999752044678},{"id":"https://openalex.org/keywords/prednisone","display_name":"prednisone","score":0.9710000157356262},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6660000085830688},{"id":"https://openalex.org/keywords/epigenetic-reprogramming","display_name":"epigenetic reprogramming","score":0.8180000185966492},{"id":"https://openalex.org/keywords/antiandrogen-therapy","display_name":"antiandrogen therapy","score":0.7630000114440918},{"id":"https://openalex.org/keywords/recommended-phase-ii-dose","display_name":"recommended phase 2 dose","score":0.734000027179718},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.734000027179718},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7639999985694885},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.7400000095367432},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.8659999966621399},{"id":"https://openalex.org/keywords/heavily-pretreated-patients","display_name":"heavily pretreated patients","score":0.5460000038146973}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8644617795944214},{"id":"https://openalex.org/C2776551883","wikidata":"https://www.wikidata.org/wiki/Q1996756","display_name":"Enzalutamide","level":5,"score":0.830053448677063},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.7231979966163635},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.6354453563690186},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5961812734603882},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5233696699142456},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4860563576221466},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.4604765474796295},{"id":"https://openalex.org/C2777899217","wikidata":"https://www.wikidata.org/wiki/Q4759439","display_name":"Androgen deprivation therapy","level":4,"score":0.4195234775543213},{"id":"https://openalex.org/C50171091","wikidata":"https://www.wikidata.org/wiki/Q17917770","display_name":"EZH2","level":4,"score":0.4170447289943695},{"id":"https://openalex.org/C61367390","wikidata":"https://www.wikidata.org/wiki/Q416601","display_name":"Androgen receptor","level":4,"score":0.2625531256198883},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.18175074458122253},{"id":"https://openalex.org/C41091548","wikidata":"https://www.wikidata.org/wiki/Q26939","display_name":"Epigenetics","level":3,"score":0.08163473010063171},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2019.37.7_suppl.tps335","doi":"https://doi.org/10.1200/jco.2019.37.7_suppl.tps335","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2019.37.7_suppl.tps335","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2792439068","https://openalex.org/W2953512664","https://openalex.org/W3007220435","https://openalex.org/W7133234479","https://openalex.org/W2885685840","https://openalex.org/W4281729065","https://openalex.org/W4410809595","https://openalex.org/W3202127151","https://openalex.org/W3049127243","https://openalex.org/W4408019665"],"abstract_inverted_index":{"TPS335":[0],"Background:":[1],"EZH2":[2,12,25,70],"is":[3,14,58,184,228,243,262],"frequently":[4],"mutated":[5],"and/or":[6],"overexpressed":[7],"in":[8,19,32,77,100,113,130,155,181,303,307],"numerous":[9],"cancers.":[10],"High":[11],"expression":[13],"correlated":[15],"with":[16,29,95,102,134,159,199,218,224,250,277],"poor":[17],"outcomes":[18],"prostate":[20,37,78],"cancer":[21,81],"patients":[22,101,116,131,150],"(Varambally,":[23],"2002).":[24],"inhibition":[26],"combines":[27],"synergistically":[28],"anti-androgen":[30],"therapies":[31],"preclinical":[33],"models":[34],"of":[35,65,92,163,196,239,272],"advanced":[36],"cancer,":[38],"suggesting":[39],"epigenetic":[40],"reprogramming":[41],"as":[42],"a":[43,59,87,119,135,251,267],"pathophysiologic":[44],"mechanism":[45],"to":[46,185],"enhance":[47],"the":[48,147,160,187,225,232,240],"combination":[49],"therapy":[50],"(Ku,":[51],"2017;":[52],"Xiao":[53],"2018;":[54],"Constellation,":[55],"unpublished).":[56],"CPI-1205":[57,93,153,197,278],"potent,":[60],"selective,":[61],"and":[62,68,79,118,141,190,209,212,289],"cofactor-competitive":[63],"inhibitor":[64],"wild":[66],"type":[67],"mutant":[69],"catalytic":[71],"activity,":[72],"which":[73,104],"demonstrates":[74],"anti-proliferative":[75],"effects":[76],"other":[80],"cell":[82],"models.":[83],"Methods:":[84],"We":[85],"present":[86],"Phase":[88,182,269],"1b/2":[89],"multicenter":[90],"study":[91,233],"combined":[94,158,198,276],"either":[96,164,200],"E":[97,165,201,273,280],"or":[98,143,170,202,274,281,297],"A/P":[99,171,275,282],"mCRPC,":[103],"includes":[105,287],"phase":[106,121,148,192],"1":[107,254],"dose":[108,162,194],"escalation,":[109],"an":[110],"expansion":[111],"cohort":[112],"heavily":[114],"pretreated":[115],"(HPEC),":[117],"randomized":[120,268],"2":[122,193,270],"study.":[123],"Key":[124],"eligibility":[125],"criteria":[126],"include":[127,206],"progressive":[128],"mCRPC":[129],"previously":[132],"treated":[133],"second-generation":[136],"androgen":[137],"inhibitor,":[138],"ECOG":[139],"0-1,":[140],"measurable":[142,255],"non-measurable":[144],"disease.":[145],"During":[146],"1b,":[149],"will":[151,265],"receive":[152],"continuously":[154],"28-day":[156],"cycles":[157],"standard":[161],"(160mg":[166],"PO":[167,173],"once":[168,174],"daily)":[169],"(1000mg":[172],"daily/5":[175],"mg":[176],"BID).":[177],"The":[178,215,236,284],"primary":[179,237],"objective":[180,244],"1b":[183],"determine":[186],"safety,":[188,207],"tolerability,":[189],"recommended":[191],"(RP2D)":[195],"A/P.":[203],"Secondary":[204],"objectives":[205],"pharmacokinetic":[208],"pharmacodynamic":[210],"profiles,":[211],"anti-tumor":[213],"activity.":[214],"HPEC":[216,241],"arm,":[217],"Simon\u2019s":[219],"2-stage":[220],"design,":[221],"may":[222],"begin":[223],"regimen":[226],"that":[227],"deemed":[229],"safe":[230],"by":[231],"safety":[234],"committee.":[235],"endpoint":[238,286],"arm":[242],"response":[245,291],"rate":[246,292],"(ORR)":[247],"per":[248,299],"PCWG3,":[249],"requirement":[252],"\u2265":[253],"lymph":[256],"node":[257],"at":[258],"baseline.":[259],"Once":[260],"RP2D":[261],"established,":[263],"we":[264],"start":[266],"trial":[271,311],"vs.":[279],"alone.":[283],"co-primary":[285],"PSA50":[288],"composite":[290],"(either":[293],"CTC":[294],"30%":[295],"reduction":[296],"ORR":[298],"PCWG3).":[300],"Patient":[301],"accrual":[302],"US":[304],"sites":[305],"began":[306],"December":[308],"2017.":[309],"Clinical":[310],"information:":[312],"NCT03480646.":[313]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":4},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2022-05-11T00:00:00"}